Home / World Marketplace / Archive by category Global Health & Biotech (Page 32)

Archive by category Global Health & Biotech

Minovia Therapeutics Announces FDA Clearance of Second IND Application, for a Phase II Clinical Trial of Lead Product MNV-201 in Pearson Syndrome

MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria Rare Pediatric Designation granted MNV-201 is also being studied in a Phase Ib for low-risk Myelodysplastic Syndrome; Preliminary clinical data demonstrate safety and efficacy HAIFA, Israel, April 03, 2025 (Korea Bizwire) – Minovia Therapeutics Ltd, a clinical stage biopharmaceutical company advancing mitochondrial therapies for primary and secondary mitochondrial diseases, today announced that the U.S. [...]

Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel

CHF 27 million investment significantly bolsters Boehringer’s ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s aim of transforming the lives of people with cancer. Boehringer Ingelheim strengthens footprint in Swiss biotech innovation hub. Basel, Switzerland, Thursday, 03.04.2025 (Korea Bizwire) –Today NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and strengthens its footprint [...]

Mitolyn Reviews (NEW MEDICAL ALERT): Doctor Uncovers the Truth About This Bio-Energy Hack for Natural Weight Loss

SEATTLE, April 02, 2025 (Korea Bizwire) – When it comes to weight loss supplements, consumer experiences and real-world results matter more than marketing hype. With Mitolyn gaining rapid attention, people are asking the same questions: Does Mitolyn actually work? Are the results consistent? What are real users saying about effectiveness and side effects (official source)? Unlike traditional weight loss [...]

Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches

Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to EUR 6.2 billion, 23.2% of group net sales Company prepares new product launches starting in 2025 Boehringer Ingelheim today announced a continued rise in the number of patients it reached, 66 million in 2024, up 8.0% from the previous year. [...]

GlucoTonic Reviews (DOCTOR INVESTIGATED): Is This Blood Sugar Breakthrough the Real Deal or Dangerous Hype

DENVER, April 01, 2025 (Korea Bizwire) – In a world where energy crashes, brain fog, and stubborn belly fat are all-too-common symptoms of unchecked blood sugar fluctuations, a new formula is making massive waves. Meet GlucoTonic—a revolutionary, all-natural supplement engineered to support healthy blood sugar levels, fire up your metabolism, and melt away excess body fat with a clinically-backed [...]

ProvaDent Reviews (DENTIST INVESTIGATED): Can This Oral Probiotic Really Strengthen Teeth and Reverse Years of Damage?

DENVER, April 01, 2025 (Korea Bizwire) – If you’ve been brushing, flossing, rinsing—and still watching your dental health decline—there’s a reason. The truth is, most people never address the root cause of chronic oral problems. That’s where ProvaDent steps in. This oral probiotic formula isn’t your average minty gimmick or overpriced mouthwash—it’s being called the “silent dental revolution” by those who’ve [...]

Respilean Review (BREAKING NEWS): Why Thousands Are Calling It the Natural Lung Breakthrough of 2025

DENVER, April 01, 2025 (Korea Bizwire) – In a world where we measure everything—from step counts to calories—there’s one thing we rarely track until it’s already compromised: our lung health. With pollution rising, allergens becoming more aggressive, and the post-viral era leaving millions with lingering shortness of breath, it’s no surprise that demand for natural respiratory support has [...]

Prime Biome (INVESTIGATIVE REPORT): Does This Trending Gut Reset Supplement Actually Deliver Real Results?

DENVER, April 01, 2025 (Korea Bizwire) – At a time when nearly every health product claims to support digestion, reduce inflammation, or rewind the clock on aging, one name is rising through the noise: Prime Biome. Promoted as a next-generation probiotic designed to rejuvenate the gut-skin connection, early buzz has left many wondering—is this truly a [...]

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-’749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

More than 92% of schizophrenia patients taking TEV-‘749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication1 New data from UZEDY® (risperidone) evaluated predictors of response in schizophrenia with efficacy observed across patient demographic and clinical characteristics in the Phase 3 RISE trial Teva continues its commitment [...]

Sandoz strengthens its balance sheet by issuing new bonds to repay spin-off term loans, and signs new USD 2 billion revolving credit facility

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN New USD 2.0 billion multi-currency revolving credit facility (RCF) in place to further strengthen Sandoz balance sheet and liquidity New facility replaces initial and unutilized USD 1.25 billion RCF, in place since spin-off in 2023 Dual-tranche CHF 400m and single-tranche EUR 500 [...]